2(E)-(4-fluorophenyl)ethenesulfonyl chloride | 315495-38-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2(E)-(4-fluorophenyl)ethenesulfonyl chloride
• 英文别名: 2-(4-fluorophenyl)ethenesulfonyl chloride；(E)-4-fluorostyrylsulfonyl chloride；(E)-2-(4-fluorophenyl)vinylsulfonyl chloride；2-(4-Fluorophenyl)ethene-1-sulfonyl chloride；(E)-2-(4-fluorophenyl)ethenesulfonyl chloride
• CAS: 315495-38-6
• 化学式: C₈H₆ClFO₂S
• 分子量: 220.652
• InChiKey: WEYVXKRBZKSRRM-AATRIKPKSA-N

物化性质

• 沸点：
  320.8±34.0 °C(Predicted)
• 密度：
  1.465±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  42.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2(E)-(4-fluorophenyl)ethenesulfonyl chloride 在 potassium carbonate 作用下， 以 甲醇 、 二氯甲烷 、 乙腈 为溶剂， 反应 12.17h， 生成 (E)-N-allyl-2-(4-fluorophenyl)-N-methylethenesulfonamide
  参考文献：
  名称：

  Desulfonylation-Initiated Distal Alkenyl Migration in Copper-Catalyzed Alkenylation of Unactivated Alkenes

  摘要：

  A novel and efficient protocol for desulfonylation-initiated distal alkenyl migration and its application to the elusive alkenylation of unactivated alkenes have been presented. This radical cascade process has successfully achieved the vicinal difluoroalkylalkenylation of unactivated alkenes with excellent chemo-, regio-, and stereoselectivity in high efficiency under mild conditions. The reactions afford previously unknown 3,3-difluoro-S-styrylpiperidin-2-one derivatives or beta-styryl-gamma-difluoroalkyl amines bearing a quaternary stereocenter. This is the first report of difunctionalization of unactivated alkenes through desulfonylation-initiated distal alkenyl migration.

  DOI：

  10.1021/acs.orglett.8b02840
• 作为产物：
  描述：

  4-氟苯乙烯 在 磺酰氯 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 生成 2(E)-(4-fluorophenyl)ethenesulfonyl chloride
  参考文献：
  名称：

  [3 + 2]甲氧亚苄基内鎓盐和乙烯基磺酰氟的环加成反应–一种吡咯烷-3-磺酰氟的方法

  摘要：

  [3 + 2]各种乙烯基磺酰氟与未取代的甲亚胺叶立德的环加成反应会形成吡咯烷-3-磺酰氟。该方法具有可扩展性，并且该产品是硫（VI）-氟化物交换（SuFEx）的合适构建基块，已被称为另一种点击反应。

  DOI：

  10.1002/ejoc.201800521

文献信息

• The Rhodium-Catalyzed Carbene Cyclization Cycloaddition Cascade Reaction of Vinylsulfonates
  作者：Bairu Shi、Sandra Merten、David K. Y. Wong、John C. K. Chu、Lok Lok Liu、Sze Kui Lam、Anne Jäger、Wing-Tak Wong、Pauline Chiu、Peter Metz

  DOI：10.1002/adsc.200900695

  日期：2009.12

  Vinylsulfonates have proved to be excellent dipolarophiles for carbonyl ylides derived from diazoketones in rhodium-catalyzed intramolecular cycloadditions. Polyfunctional substrates, such as 8 and (+)-15, were readily available from hydroxy esters, e.g. 1 and the cyclopenta-1,3-dione 10, respectively, and the resulting polycyclic sultones were formed under mild reaction conditions in high yields with

  对于铑催化的分子内环加成反应中的重氮酮类衍生的羰基羰基化物，乙烯基磺酸盐已被证明是极好的偶极亲和性。多官能底物（例如8和（+）- 15）可分别分别从羟基酯（例如1和环戊-1,3-二酮10）获得，并且在温和的反应条件下以高收率形成高产率的多环磺内酯。非常好的非对映选择性。发现钌催化的不对称转移氢化可有效地使内消旋-环戊-1,3-二酮12脱对称。
• SUBSTITUTED BENZOYLGUANIDINES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT OR DIAGNOSTIC AND MEDICAMENT COMPRISING THE SAME
  申请人：Kleemann Heinz-Werner

  公开号：US20070270414A1

  公开（公告）日：2007-11-22

  The present invention relates to substituted benzoylguanidines of the formula I: in which R1 to R8 and X and Y are as described in the specification, and their pharmaceutically acceptable salts are substituted acylguanidines as inhibitors of the cellular sodium-proton antiporter (Na + /H + exchanger, NHE).

  本发明涉及式I的取代苯甲酰胍类化合物： 其中R1至R8和X和Y如规范中所述，并且它们的药用盐是细胞钠质子抗体转运蛋白(Na+/H+交换蛋白，NHE)的取代酰胍类化合物抑制剂。
• N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
  申请人：——

  公开号：US20020165412A1

  公开（公告）日：2002-11-07

  N-(Aryl)-2-arylethenesulfonamides and pharmaceutically acceptable salts and compositions thereof are useful as antiproliferative agents, including, for example, anticancer agents. They are also useful as radioprotective agents.

  N-(芳基)-2-芳基乙烯磺酰胺及其药学上可接受的盐和组合物可用作抗增殖剂，包括例如抗癌剂。它们也可用作放射保护剂。
• Bicyclic piperazine compound and use thereof
  申请人：Fukatsu Kohji

  公开号：US20070072865A1

  公开（公告）日：2007-03-29

  The present invention provides a compound represented by the formula: wherein R 1 is an acyl group, R 2 is a hydrocarbon group which may be substituted or the like, R 3 is a hydrocarbon group which may be substituted or the like, R 4 is a hydrocarbon group which may be substituted or the like, n is from 0 to 4, and X is an oxygen atom, a sulfur atom or the like, or a salt thereof. The invention also provides a compound which has a TGR23 antagonist activity and thus is useful for prevention and treatment of cancer.

  本发明提供一种化合物，其化学式为：其中，R1是酰基，R2是烃基，可以被取代或类似物，R3是烃基，可以被取代或类似物，R4是烃基，可以被取代或类似物，n为0至4，X为氧原子、硫原子或类似物或其盐。本发明还提供一种具有TGR23拮抗活性的化合物，因此可用于预防和治疗癌症。
• Bicyclic piperazine compound having TGR23 antagonistic activity
  申请人：Takeda Pharmaceutical Company Limited

  公开号：US07795267B2

  公开（公告）日：2010-09-14

  The present invention provides a compound represented by the formula: wherein R1 is —(C═O)—NR7R8 or —(C═O)—OR6, R2 is a hydrocarbon group which may be substituted or the like, R3 is a hydrocarbon group which may be substituted or the like, R4 is a hydrocarbon group which may be substituted or the like, n is from 0 to 4, and X is an oxygen atom, or a salt thereof. The invention also provides a compound which has a TGR23 antagonist activity and thus is useful for prevention and treatment of cancer.

  本发明提供了一种化合物，其表示为以下公式：其中R1为—（C═O）—NR7R8或—（C═O）—OR6，R2为可取代或类似的烃基，R3为可取代或类似的烃基，R4为可取代或类似的烃基，n为0至4，X为氧原子或其盐。本发明还提供了一种具有TGR23拮抗活性的化合物，因此可用于预防和治疗癌症。